Effectiveness and Safety of New Chemotherapy Regimens in Patients with HIV-associated MDR TB and Viral Hepatitis C
The objective: to study the effectiveness and safety of new chemotherapy regimens at the end of the intensive phase in the patients suffering from multiple drug resistant tuberculosis (MDR TB), concurrent HIV infection (HIV), and chronic hepatitis C (HCV).Subjects and Methods. The effectiveness and saf...
Saved in:
| Main Authors: | A. V. Kukurika, A. B. Peregudova, L. E. Parolina, T. V. Pyanzova, E. O. Bryukhacheva, O. V. Serdyuk |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2024-12-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of unfavourable treatment outcomes for HIV-associated MDR-TB in patients with viral hepatitis C
by: A. V. Kukurika
Published: (2024-07-01) -
Safety of chemotherapy of MDR/XDR-TB patients in high HIV prevalence settings
by: A. V. Kukurika, et al.
Published: (2022-12-01) -
CHRONIC VIRAL HEPATITIS, TUBERCULOSIS, AND HIV AS COMORBIDITY: FROM THEORY TO PRACTICE
by: V. V. Nechaev, et al.
Published: (2018-01-01) -
Viral hepatitis
by: D. Brink
Published: (2006-09-01) -
Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis
by: V. V. Karabaeva, et al.
Published: (2021-11-01)